Adenovirus E1A proteins inhibit activation of transcription by p53

Molecular and Cellular Biology

Volumn 16, Issue 5, 1996, Pages 2101-2109

  Steegenga, Wilma T ^a   Van Laar, Theo ^a   Riteco, Nicole ^a   Mandarino, Angelo ^a   Shvarts, Avi ^a   Van Der Eb, Alex J ^a   Jochemsen, A G ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADENOVIRUS; AMINO TERMINAL SEQUENCE; ARTICLE; CELL CYCLE G1 PHASE; CELL TRANSFORMATION; DNA BINDING; DNA DAMAGE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; TRANSCRIPTION INITIATION;

ADENOVIRIDAE; HUMAN ADENOVIRUS TYPE 2;

EID: 0029863824     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.5.2101     Document Type: Article

References (68)

1. Agoff, S. N., J. Hou, D. I. Linzer, and B. Wu. 1993. Regulation of the human hsp70 promoter by p53. Science 259:84-87.
2. Barak, Y., T. Juven, R. Haffner, and M. Oren. 1993. mdm2 expression is induced by wild type p53 activity EMBO J. 12:461-468.
3. Boyle, W. J., P. van der Geer, and T. Hunter. 1991. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201:110-149.
4. Caelles, C., A. Helmberg, and M. Karin. 1994. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes Nature (London) 370:220-223
5. Chiou, S.-K., L. Rao, aud E. White. 1994. Bcl-2 blocks p53-dependent apoptosis. Mol. Cell. Biol. 14:2556-2563
6. Cross, S. M., C. A. Sanchez, C. A. Morgan, M. K. Schimke, S. Ramel, R. L. Idzerda, W. H. Raskind, and B. J. Reid. 1995. A p53-dependent mouse spindle checkpoint. Science 267:1353-1356.
7. Deb, S. P., R. M. Munoz, D. R. Brown, M. A. Subler, and S. Deb. 1994 Wild-type human p53 activates the human epidermal growth factor receptor promoter. Oncogene 9:1341-1349.
8. Debbas, M., and E. White. 1993. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7:546-554.
9. Dittmer, D., S. Pati, G. Zambetti, S. Chu, A. K. Teresky, M. Moore, C. Finlay, and A. J. Levine. 1993. Gam of function mutations in p53. Nat. Genet. 4:42-46.
10. Egan, C., T. N. Jelsma, J. A. Howe, S. T. Bayley, B. Ferguson, and P. E. Branton. 1988. Mapping of cellular protein-binding sites on the produce of early-region 1A of human adenovirus type 5 Mol. Cell. Biol. 8:3955-3959.
11. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kanzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression Cell 75:817-825.
12. Fields, S., and S. K. Jang. 1990. Presence of a potent transcription activating sequence in the p53 protein. Science 249:1046-1049
13. Fritsche, M., C. Haessler, and C. Brandner. 1993. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 8:307-318.
14. Garvin, A. J., G. G. Re, B. I. Tarnowski, D. J. Hazen-Martin, and D. A. Sens. 1993. The G401 cell line, utilized for studies of chromosomal changes in Wilms' tumor, is derived from a rhabdoid tumor of the kidney. Am. J Pathol. 142:375-380.
15. Ginsberg, D., F. Mechta, M. Yaniv, and M. Oren. 1991. Wild-type p53 can down-modulate the activity of various promoters. Proc. Natl Acad. Sci USA 88:9979-9983.
16. Halazonetis, T. D., L. J. Davis, and A. N. Kandil. 1993. Wild-type p53 adopts a "mutant"-like conformation when bound to DNA EMBO J. 12:1021-1028.
17. Horikoshi, N., A. Usheva, J. Chen, A. J. Levine, R. Weinmann, and T. Shenk. 1995 Two domains of p53 interact with the TATA-binding protein, and the adenovirus 13S E1A protein disrupts the association, relieving p53-mediated transcriptional repression Mol. Cell. Biol. 15:227-234.
18. Jochemsen, A. G., L. T. C. Peltenburg, M. F. W. te Pas, C. M. de Wit, J. L. Bos, and A. J. van der Eb. 1987. Activation of adenovirus 5 E1A transcription by region E1B in transformed primary rat cells. EMBO J 6:3399-3405.
19. Kastan, M. B., Q. Zhan, W. S. El-Deiry, F. Carrier, T. Jacks, W. V. Walsh, B. S. Plunkett, B. Vogelstein, and A. J. Fornace, Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxiatelangiectasia. Cell 71:587-597.
20. Kern, S. E., J. A. Pietenpol, S. Thiagalingam, A. Seymour, K. W. Kinzler, and B. Vogelstein. 1992. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256:827-830.
21. Kuerbitz, S. J., B. S. Plunkett, W. V. Walsh, and M. B. Kastan. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation Proc Natl. Acad. Sci. USA 89:7491-7495.
22. Lane, D.P. 1992. p53, guardian of the genome. Nature (London) 358:15-16.
23. Lee, W. S., C. C. Kao, G. O. Bryant, X. Liu, and A. J. Berk. 1991. Adenovirus E1A activation domain binds the basic repeat in the TATA box transcription factor Cell 67:365-376.
24. Lin, J., A. K. Teresky, and A. J. Levine. 1995. Two critical hydrophobic ammo acids in the N-terminal domain of the p53 protein are required for the gam of function phenotypes of human p53 mutants. Oncogene 10:2387-2390.
25. Liu, X., C. W. Miller, P. H. Koeffler, and A. J. Berk. 1993. The p53 activation domain binds the TATA box-binding polypeptide in holo-TFIID, and a neighboring p53 domain inhibits transcription. Mol. Cell. Biol. 13:3291-3300
26. Lowe, S. W., T. Jacks, D. E. Housman, and H. E. Ruley. 1994. Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc Natl. Acad. Sci. USA 91:2026-2030.
27. Lowe, S. W., and H. E. Ruley. 1993. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. Genes Dev. 7:535-545.
28. Lowe, S. W., E. M. Schmitt, S. W. Smith, B. A. Osborne, and T. Jacks. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (London) 362:847-849
29. Maltzman, W., and L. Czyzyk. 1984. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. Biol. 4:1689-1694
30. Martinou, I., P. A. Fernandez, M. Missotten, E. White, B. Allet, R. Sadoul, and J. C. Martinou. 1995. Viral proteins E1B19K and p35 protect sympathetic neurons from cell death induced by NGF deprivation. J Cell Biol 128:201-208.
31. Masuda, H., C. Miller, H. P. Koeffler, H. Battifora, and M. J. Cline. 1987. Rearrangement of the p53 gene in human osteogenic sarcomas. Proc Natl. Acad Sci. USA 84:7716-7719.
32. Meek, D. W. 1994 Post-translational modification of p53. Semin Cancer Biol 5:203-210
33. Mercer, W. E., M. T. Shields, D. Lin, E. Appella, and S. J. Ullrich. 1991. Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression. Proc Natl. Acad. Sci. USA 88:1958-1962
34. Miyashita, T., M. Harigai, M. Hanada, and J. C. Reed. 1994. Identification of a p53-negative response element in the bcl-2 gene. Cancer Res. 54:3131-3135
35. Miyashita, T., S. Krajewski, M. Krajewski, H. G. Wang, H. K. Lin, D. A. Liebermann, B. Hoffman, and J. C. Reed. 1994. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799-1805.
36. Miyashita, T., and J. C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299.
37. Offringa, R., S. Gebel, H. van Dam, M. Timmers, A. Smits, R. Zwart, B. Stein, J. L. Bos, A. J. van der Eb, and P. Herrlich. 1990. A novel function of the transforming domain of E1a: repression of AP-1 activity. Cell 62:527-538
38. Okamoto, K., and D. Beach. 1994 Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J. 13:4816-4822.
39. Price, B. D., and S. J. Park. 1994. DNA damage increases the levels of MDM2 messenger RNA in wtp53 human cells. Cancer Res. 54:896-899
40. Puisieux, A., K. Galvin, F. Troalen, B. Bresse, C. Marcais, E. Galun, F. Ponchel, C. Yakicier, J. Ji, and M. Ozturk. 1993. Retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines. FASEB J. 7:1407-1413
41. Ragimov, N., A. Krauskopf, N. Navot, V. Rotter, M. Oren, and Y. Aloni. 1993. Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif. Oncogene 8:1183-1193.
42. Rao, L., M. Debbas, P. Sabbatini, D. Hockenbery, S. Korsmeyer, and E. White. 1992 The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins Proc. Natl. Acad. Sci. USA 89:7742-7746.
43. Raycroft, L., H. Y. Wu, and G. Lozano. 1990. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science 249:1049-1051.
44. Sabbatini, P., S.-K. Chiou, L. Ran, and E. White. 1995. Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein. Mol. Cell. Biol. 15:1060-1070.
45. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed., 7.43-7.48. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
46. Santhanam, U., A. Ray, and P. B. Sehgal. 1991. Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc Natl. Acad. Sci. USA 88:7605-7609.
47. Selvakumaran, M., H. K. Lin, T. Miyashita, H. G. Wang, S. Krajewski, J. C. Reed, B. Hoffman, and D. Liebermann. 1994. Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. Oncogene 9:1791-1798.
48. Seto, E., A. Usheva, G. P. Zambetti, J. Momand, N. Horikoshi, R. Weinmann, A. J. Levine, and T. Shenk. 1992. Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc. Natl. Acad. Sci. USA 89:12028-12032.
49. Shen, Y., and T. Shenk. 1994. Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein. Proc. Natl. Acad. Sci. USA 91:8940-8944.
50. Steegenga, W. T., A. Shvarts, T. van Laar, A. J. van der Eb, and A. G. Jochemsen. 1995. Altered phosphorylation and oligomerization of p53 in adenovirus type 12-transformed cells. Oncogene 11:49-57.
51. Steegenga, W. T., T. van Laar, A. Shvarts, C. Terleth, A. J. van der Eb, and A. G. Jochemsen. 1995. Distinct modulation of p53 activity in transcription and cell-cycle regulation by the large (54 kDa) and the small (21k Da) adenovirus E1B proteins. Virology 212:543-554.
52. Sturzbecher, H. W., R. Brain, C. Addison, K. Rudge, M. Remm, M. Grimaldi, E. Keenan, and J. R. Jenkins. 1992. A C-terminal alpha-helix plus basic region motif is the major structural determinant of p53 tetramerization. Oncogene 7:1513-1523.
53. Subler, M. A., D. W. Martin, and S. Deb. 1992. Inhibition of viral and cellular promoters by human wild-type p53. J. Virol. 66:4757-4762
54. Teodoro, J. G., G. C. Shore, and E. P. Branton. 1995. Adenovirus E1A proteins induce apoptosis by both p53-dependent and p53-independent mechanisms. Oncogene 11:467-474.
55. Thut, C. J., J. L. Chen, R. Klemm, and R. Tjian. 1995. p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60 Science 267:100-104.
56. Truant, R., H. Xiao, C. J. Ingles, and J. Greenblatt. 1993. Direct interaction between the transcriptional activation domain of human p53 and the TATA box-binding protein. J. Biol. Chem. 268:2284-2287
57. Unger, T., M. M. Nau, S. Segal, and J. D. Minna. 1992. p53: a transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer. EMBO J. 11:1383-1390.
58. van den Heuvel, S. J. L., T. van Laar, I. The, and A. J. van der Eb. 1993. Large E1B proteins of adenovirus types 5 and 12 have different effects on p53 and distinct roles in cell transformation. J. Virol. 67:5226-5234.
59. Van der Eb, A. J., and F. L. Graham. 1980 Assay of transforming activity of tumor virus DNA. Methods Enzymol. 65:826-839.
60. Wagner, A. J., J. M. Kokontis, and N. Hay. 1994. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev. 8:2817-2830.
61. Wang, X. W., H. Yen, L. Schaeffer, R. Roy, V. Moncollin, J. M. Egly, Z. Wang, E. C. Friedberg, M. K. Evans, B. G. Taffe, V. A. Bohr, G. Weeda, J. H. J. Hoeijmakers, K. Forrester, and C. C. Harris. 1995. p53 modulation of TFIIH-associated nucleotide excision repair activity Nat. Genet. 10:188-195.
62. Weissman, B. E., P. J. Saxon, S. R. Pasquale, G. R. Jones, A. G. Geiser, and E. J. Stanbridge. 1987. Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression Science 236: 175-180.
63. Whyte, P., N. M. Williamson, and E. Harlow. 1989. Cellular targets for transformation by the adenovirus E1A proteins. Cell 56:67-75.
64. Wu, X., J. H. Bayle, D. Olson, and A. J. Levine. 1993. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7:1126-1132
65. Xiao, H., A. Pearson, B. Coulombe, R. Truant, S. Zhang, J. L. Regier, S. J. Triezenberg, D. Reinberg, O. Flores, C. J. Ingles, and J. Greenblatt. 1994. Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol Cell. Biol. 14:7013-7024.
66. Yew, P. R., and A. J. Berk. 1992 Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature (London) 357: 82-85.
67. Zauberman, A., A. Lupo, and M. Oren. 1995 Identification of p53 target genes through immune selection of genomic DNA: the cyclin G gene contains two distinct p53 binding sites Oncogene 10:2361-2366.
68. Zhan, Q., F. Carrier, and A. J. Fornace, Jr. 1993. Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol. Cell Biol, 13: 4242-4250.